Literature DB >> 34145040

Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?

Laura A Sena1, Samuel R Denmeade2,3.   

Abstract

Tumor metabolism supports the energetic and biosynthetic needs of rapidly proliferating cancer cells and modifies intra- and intercellular signaling to enhance cancer cell invasion, metastasis, and immune evasion. Prostate cancer exhibits unique metabolism with high rates of de novo fatty acid synthesis driven by activation of the androgen receptor (AR). Increasing evidence suggests that activation of this pathway is functionally important to promote prostate cancer aggressiveness. However, the mechanisms by which fatty acid synthesis are beneficial to prostate cancer have not been well defined. In this review, we summarize evidence indicating that fatty acid synthesis drives progression of prostate cancer. We also explore explanations for this phenomenon and discuss future directions for targeting this pathway for patient benefit. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34145040      PMCID: PMC8416800          DOI: 10.1158/0008-5472.CAN-21-1392

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  125 in total

1.  Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2.

Authors:  Xiaochao Wei; Zhen Yang; Federico E Rey; Vanessa K Ridaura; Nicholas O Davidson; Jeffrey I Gordon; Clay F Semenkovich
Journal:  Cell Host Microbe       Date:  2012-02-16       Impact factor: 21.023

2.  Metabolomic signatures of aggressive prostate cancer.

Authors:  Jonathan E McDunn; Zhen Li; Klaus-Peter Adam; Bruce P Neri; Robert L Wolfert; Michael V Milburn; Yair Lotan; Thomas M Wheeler
Journal:  Prostate       Date:  2013-07-03       Impact factor: 4.104

Review 3.  Targeting Metabolism for Cancer Therapy.

Authors:  Alba Luengo; Dan Y Gui; Matthew G Vander Heiden
Journal:  Cell Chem Biol       Date:  2017-09-21       Impact factor: 8.116

4.  Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP.

Authors:  J V Swinnen; P P Van Veldhoven; M Esquenet; W Heyns; G Verhoeven
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

5.  Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling.

Authors:  Xiangyan Li; Yi-Ting Chen; Peizhen Hu; Wen-Chin Huang
Journal:  Mol Cancer Ther       Date:  2014-02-03       Impact factor: 6.261

6.  Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.

Authors:  Weibo Zhou; P Jeanette Simpson; Jill M McFadden; Craig A Townsend; Susan M Medghalchi; Aravinda Vadlamudi; Michael L Pinn; Gabriele V Ronnett; Francis P Kuhajda
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

7.  Stromal CAVIN1 Controls Prostate Cancer Microenvironment and Metastasis by Modulating Lipid Distribution and Inflammatory Signaling.

Authors:  Jin-Yih Low; W Nathaniel Brennen; Alan K Meeker; Elina Ikonen; Brian W Simons; Marikki Laiho
Journal:  Mol Cancer Res       Date:  2020-06-03       Impact factor: 5.852

8.  Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells.

Authors:  Caroline A Lewis; Seth J Parker; Brian P Fiske; Douglas McCloskey; Dan Y Gui; Courtney R Green; Natalie I Vokes; Adam M Feist; Matthew G Vander Heiden; Christian M Metallo
Journal:  Mol Cell       Date:  2014-05-29       Impact factor: 19.328

9.  Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.

Authors:  Jingjing Chen; Ilaria Guccini; Diletta Di Mitri; Daniela Brina; Ajinkya Revandkar; Manuela Sarti; Emiliano Pasquini; Abdullah Alajati; Sandra Pinton; Marco Losa; Gianluca Civenni; Carlo V Catapano; Jacopo Sgrignani; Andrea Cavalli; Rocco D'Antuono; John M Asara; Andrea Morandi; Paola Chiarugi; Sara Crotti; Marco Agostini; Monica Montopoli; Ionica Masgras; Andrea Rasola; Ramon Garcia-Escudero; Nicolas Delaleu; Andrea Rinaldi; Francesco Bertoni; Johann de Bono; Arkaitz Carracedo; Andrea Alimonti
Journal:  Nat Genet       Date:  2018-01-15       Impact factor: 38.330

View more
  5 in total

Review 1.  A "Weird" Mitochondrial Fatty Acid Oxidation as a Metabolic "Secret" of Cancer.

Authors:  Zhivko Zhelev; Ichio Aoki; Dessislava Lazarova; Tatyana Vlaykova; Tatsuya Higashi; Rumiana Bakalova
Journal:  Oxid Med Cell Longev       Date:  2022-02-08       Impact factor: 6.543

Review 2.  Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents.

Authors:  Disha Shah; Sankha Bhattacharya
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-21       Impact factor: 4.322

3.  Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells.

Authors:  Pablo Sanchis; Nicolas Anselmino; Sofia Lage-Vickers; Agustina Sabater; Rosario Lavignolle; Estefania Labanca; Peter D A Shepherd; Juan Bizzotto; Ayelen Toro; Antonina Mitrofanova; Maria Pia Valacco; Nora Navone; Elba Vazquez; Javier Cotignola; Geraldine Gueron
Journal:  Cancers (Basel)       Date:  2022-04-21       Impact factor: 6.575

Review 4.  Over-Reduced State of Mitochondria as a Trigger of "β-Oxidation Shuttle" in Cancer Cells.

Authors:  Zhivko Zhelev; Akira Sumiyoshi; Ichio Aoki; Dessislava Lazarova; Tatyana Vlaykova; Tatsuya Higashi; Rumiana Bakalova
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

Review 5.  Crosstalk between Statins and Cancer Prevention and Therapy: An Update.

Authors:  Beniamin Oskar Grabarek; Dariusz Boroń; Emilia Morawiec; Piotr Michalski; Veronica Palazzo-Michalska; Łukasz Pach; Barbara Dziuk; Magdalena Świder; Nikola Zmarzły
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.